AstraZeneca PLC (AZN)
181.58
-3.38
(-1.83%)
USD |
NYSE |
May 15, 16:00
181.19
-0.39
(-0.21%)
After-Hours: 20:00
AstraZeneca Market Cap : 281.60B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 99.71B |
| Johnson & Johnson | 545.74B |
| Eli Lilly & Co. | 896.13B |
| Merck & Co., Inc. | 275.09B |
| Novo Nordisk A/S | 198.33B |
Market Cap Related Metrics
| PE Ratio | 54.53 |
| PS Ratio | 9.374 |
| PEG Ratio | 1.604 |
| Price to Book Value | 5.949 |
| Price to Free Cash Flow | 70.41 |
| Price | 181.58 |
| Earnings Yield | 1.83% |
| PEGY Ratio | 1.525 |
| Operating PE Ratio | 40.35 |
| Normalized PE Ratio | 53.90 |